ArticleNeurotoxicity research2025
Distinct and Additive Effects of Long Noncoding RNA-expression and Retinoic Acid-treatment During Neuronal Differentiation of Human Neuroblastoma Cells.
Article in Neurotoxicity research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Retinoic Acid and Long Noncoding RNAs Crosstalk: Implications for Neuronal Differentiation and Diseases.Molecular neurobiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Retinoic Acid (RA) induces differentiation and regulates gene expression through three subtypes (α, β, γ) of the nuclear retinoid receptor heterodimer (RAR/RXR), which also function as transcription factors. Earlier, we reported the long intergenic noncoding RNAs (LINC-RBE and LINC-RSAS) induced by All-Trans Retinoic Acid (ATRA) in cultured primary hippocampal neurons from adult rat brain at transcriptional and post-transcriptional levels, respectively. In this study, we report that ~ 25% of the human neuroblastoma (SH-SY5Y) cells were differentiated by 1 µM ATRA-treatment within 72 h showing extension of neurites from spindle-shaped cells demonstrating neuronal differentiation. Expression of RARβ and interferon regulatory factor-1 (IRF-1) mRNAs was significantly upregulated up to 16xfold at 10 h and 2.6xfold at 8 h by 1 µM ATRA-treatment, respectively. This indicated activation of the RA-signaling pathway in these cells. With a transfection efficiency of ~ 40%, overexpression of LINC-RBE and LINC-RSAS caused ~ 34% and ~ 33% inhibition of cell proliferation, respectively, with an increase in cell death and ~ 10% reduction in number of cells in G1-phase of cell cycle. ATRA-treatment alone caused ~ 40% inhibition of cell proliferation, and induced ~ 66% of cells to G1-phase arrest. Combined effect of LINC-RSAS + ATRA further enhanced inhibition of cell proliferation by additional ~ 32%, whereas LINC-RBE, ATRA and LINC-RBE + ATRA showed similar effects indicating distinct effects and mechanisms of their actions. Moreover, overexpression of these lncRNAs led to fourfold increase in genomicDNA breakage/damage in these cells. Thus it showed an unique relationship between lncRNA and RA during neuronal differentiation, most likely involving regulation of gene expression.
Indexed as
Identifiers
41108347What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.